Skip to main content
Premium Trial:

Request an Annual Quote

Warnex Will Use LC/MS and PCR Tools in PGx Study of Gleevec for Novartis

NEW YORK (GenomeWeb News) — Warnex today said Novartis has hired it to perform bioanalytical and pharmacogenetic services for the drug maker’s leukemia and intestinal tumors program.

Warnex said its Bioanalytical Services division will use its liquid chromatography and mass spec technologies to test blood levels of Novartis’ drug Gleevec to “help identify non-adherence or suboptimal dosing.”

Warnex also will perform PCR-based diagnostic tests to determine if patients have chromosomal abnormalities.

Financial terms of the agreement were not released.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.